ICOS and rheumatoid arthritis: In contrast, circulating ICOS+ Tfh cells are markedly increased in patients with autoimmune diseases, including systemic lupus erythematosus, Sjogren’s syndrome, rheumatoid arthritis, and dermatomyositis [19, 30–34].